Survival and prognostic factors after adjuvant 131iodine-labeled lipiodol for hepatocellular carcinoma: a retrospective analysis of 106 patients over 20 years.
Olesinski J, Mithieux F, Guillaud O, Hilleret MN, Lombard-Bohas C, Henry L, Boillot O, Walter T, Partensky C, Paliard P, Valette PJ, Vuillez JP, Borson-Chazot F, Scoazec JY, Dumortier J.
Olesinski J, et al. Among authors: partensky c.
Ann Nucl Med. 2017 Jun;31(5):379-389. doi: 10.1007/s12149-017-1165-4. Epub 2017 Mar 24.
Ann Nucl Med. 2017.
PMID: 28342103